Bank of America Corp DE increased its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 86.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 128,048 shares of the company's stock after purchasing an additional 59,245 shares during the period. Bank of America Corp DE owned approximately 0.26% of Guardian Pharmacy Services worth $4,822,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in GRDN. First Trust Advisors LP bought a new stake in Guardian Pharmacy Services during the first quarter worth about $3,528,000. TimesSquare Capital Management LLC grew its stake in shares of Guardian Pharmacy Services by 21.9% in the 4th quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company's stock worth $31,538,000 after buying an additional 187,963 shares during the last quarter. Jennison Associates LLC bought a new position in Guardian Pharmacy Services during the 4th quarter valued at approximately $3,489,000. Dimensional Fund Advisors LP raised its stake in Guardian Pharmacy Services by 200.0% during the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company's stock valued at $7,855,000 after buying an additional 139,070 shares during the last quarter. Finally, Globeflex Capital L P purchased a new position in Guardian Pharmacy Services during the fourth quarter valued at $1,335,000.
Guardian Pharmacy Services Trading Down 0.1%
NYSE:GRDN opened at $37.29 on Friday. Guardian Pharmacy Services, Inc. has a 12-month low of $23.14 and a 12-month high of $47.02. The stock has a market capitalization of $1.86 billion, a P/E ratio of 36.20, a P/E/G ratio of 1.93 and a beta of 0.10. The stock has a 50-day moving average price of $39.89 and a 200 day moving average price of $37.88.
Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.03. The firm had revenue of $351.77 million for the quarter, compared to analysts' expectations of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. On average, research analysts predict that Guardian Pharmacy Services, Inc. will post 1.19 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts recently issued reports on the stock. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, August 20th. Truist Financial boosted their price target on Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a "buy" rating in a research note on Wednesday, June 17th. Zacks Research downgraded Guardian Pharmacy Services from a "strong-buy" rating to a "hold" rating in a report on Monday, May 11th. Oppenheimer boosted their price objective on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an "outperform" rating in a report on Friday, August 7th. Finally, Wall Street Zen raised Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a report on Sunday, August 9th. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Guardian Pharmacy Services currently has a consensus rating of "Moderate Buy" and an average target price of $43.83.
Read Our Latest Stock Report on GRDN
Guardian Pharmacy Services Profile
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.
See Also
Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
